Sanofi, FR0000120578

Sanofi highlights vaccine and drug portfolio, shares tracked against global pharma peers

23.06.2026 - 08:00:45 | ad-hoc-news.de

Sanofi opens the week without major corporate headlines but with its broad vaccines and specialty-care portfolio in focus as investors compare the French group’s valuation and pipeline to global peers such as Pfizer and Novartis.

Sanofi, FR0000120578
Sanofi, FR0000120578

By Thomas Klein, Operations & Strategy desk. Reviewed prior to publication on 2026-06-23, 07:57.

Sanofi (FR0000120578) starts the new trading week with its broad pharmaceuticals and vaccines business in focus. On the NYSE, the Sanofi American Depositary Shares recently closed at around 41.8 US dollars on June 22, 2026, according to market data.

How Sanofi compares in pharma

The Sanofi ADSs trade on the NYSE under the ticker SNY, putting the French group alongside global peers such as Pfizer, Novartis and Eli Lilly in US trading benchmarks. Sanofi’s market value stands in the tens of billions of dollars, reflecting its role as a major global drugmaker.

In recent sessions, Sanofi shares in New York have been changing hands in the low-40-dollar range, with modest day-to-day moves reported by US price services. This places the group on valuation metrics that many investors compare with other large-cap pharmaceutical and biotech names on the S&P 500 health-care roster.

Analyst focus on earnings power

Analyst coverage of Sanofi in the US and Europe frequently highlights the contribution from its vaccines and immunology franchises and the resulting earnings power over the medium term. Commentary from broker platforms tracks how Sanofi’s pipeline and product launches stack up against rivals when it comes to revenue visibility and margins.

Market observers on platforms such as MarketBeat and other financial news aggregators regularly discuss Sanofi’s share performance relative to global health-care indices, with attention on upcoming quarterly updates and any strategic shifts.

Go deeper

All news and analysis on the Sanofi shares

Further updates, background and price data on the Sanofi equity can be found in the dedicated topic section and via the company’s Investor Relations pages.

The medicines behind the stock

Sanofi’s business centers on prescription medicines and vaccines, including therapies in immunology, oncology, rare diseases and diabetes as well as pediatric and travel vaccines. Flagship products and pipeline assets aim to support recurring revenue streams and long-term cash generation for the group.

Where the shares trade today

The Sanofi American Depositary Shares (FR0000120578) last closed on the NYSE at about 41.8 US dollars on 2026-06-22, based on publicly available price data.

Sanofi at a glance

  • Company: Sanofi S.A.
  • ISIN: FR0000120578
  • Ticker: SNY
  • Trading venue: NYSE
  • Price (as of 2026-06-22, 16:00): 41.8 USD
  • Sector / industry: Pharmaceuticals & Biotechnology
  • Index membership: CAC 40 (via the Paris listing)
  • Next earnings date: not officially scheduled

Sanofi on social media and video platforms

This text is for informational purposes only and does not constitute investment advice or a solicitation to buy or sell any financial instrument.

en | FR0000120578 | SANOFI | boerse | 69608115 | bgmi